back to top
JammuIndia's 1st indigenous Hepatitis A vaccine launched by Indian Immunologicals

India’s 1st indigenous Hepatitis A vaccine launched by Indian Immunologicals

Date:

Tawi:Indian Immunologicals Ltd (IIL) a wholly owned subsidiary of Dairy Development Board (NDDB) and a leading biopharmaceutical company in marks a historic moment in public with the launch of India's first indigenously developed Hepatitis A vaccine “Havisure®”. The vaccine represents a significant step forward in India's fight against Hepatitis A and is poised to make a substantial contribution to public health.

The new vaccine, Havisure® is the result of extensive research and development efforts by IIL's dedicated team of scientists and researchers.

This Novel Vaccine launch event was held today at Hyatt Place, Hyderabad. Chief guests were Shri Nagaraj Karpan, MLA and Shri Ajay Mishra, IAS-Chairman Indian Redcross Society, Telangana.

Speaking on the occasion, Dr. K Anand Kumar, Managing Director, Indian Immunologicals Ltd shared “The launch of Havisure® is a testament to our commitment to advancing healthcare solutions for the nation. Currently Hepatitis A vaccines are imported into our country and as a true meaning of Atma Nirbhar Bharat, IIL has tirelessly put in efforts and developed India's 1st vaccine for Hepatitis A. The vaccine Havisure® has undergone extensive clinical trials in 8 centers and has proven to be safe and efficacious. The vaccine is comparable to the world's leading vaccine sold by a multinational. With Havisure®, we aim to contribute significantly to the prevention of this infectious disease. IIL launching three vaccines in a single year is itself a big achievement and full credit to my team.”

“Havisure” is set to play a crucial role to protect against the Hepatitis A virus, which primarily affects the liver. The vaccine is effective in preventing the disease and is recommended for children in the routine immunization. It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination.

Discussing on manufacturing capabilities of IIL, Dr. Priyabrata Pattnaik, Dy. Managing Director-IIL said, “The company has considerably invested in state-of-the-art manufacturing facilities to scale up production and meet the growing demand for Hepatitis A vaccine. As part of the launch, IIL will be collaborating with healthcare professionals, corporate hospitals, and government agencies to promote awareness about Hepatitis A and the importance of both paediatric, adolescent & adult vaccination”.

 

Northlines
Northlines
The Northlines is an independent source on the Web for news, facts and figures relating to Jammu, Kashmir and Ladakh and its neighbourhood.

Share post:

Popular

More like this
Related

Jammu witness heavy rainfall; elderly woman dies

Normal life affected; Fresh snowfall in higher reaches, Sgr-Jmu...

Heavy rains keep people away from polling booths

Amir Tantray Kathua/Udhampur/Doda, Apr 19: The erratic weather conditions with intermittent...

2 labourers die after falling into trench in Kulgam

Srinagar, Apr 19: At least two labourers died and...

LG Sinha calls for an approach towards skill development

Jammu Tawi, Apr 19: Lieutenant Governor Manoj Sinha on...